Meralys 0,5 Mg/Ml

Xylometazoline Hydrochloride, the active ingredient in Meralys 0,5 Mg/Ml, is a alpha‑adrenergic agonist presented as a 0.5 mg/mL nasal solution for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in both adults and children.

GNH USA supplies Meralys 0,5 Mg/Ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

- Common cold: alleviates nasal congestion by reducing mucosal edema. - Sinusitis: improves nasal airflow and relieves sinus pressure. - Allergic rhinitis: decreases nasal blockage caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Sneezing: transient increase in sneezing episodes. - Dryness: nasal mucosa dryness or crusting. - Headache: mild headache.

Serious or Rare Side Effects: - Rebound congestion: worsening nasal blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heartbeat (rare).

When using Xylometazoline Hydrochloride nasal solution, certain precautions should be observed to ensure safety and effectiveness.

- Duration of use: limit to no more than 3‑5 consecutive days to avoid rebound congestion. - Underlying conditions: avoid in patients with severe hypertension or coronary artery disease without medical advice. - Age restrictions: not recommended for children under 6 years unless directed by a healthcare professional. - Pregnancy and lactation: use only if clearly needed and prescribed by a physician. - Drug interactions: consult a clinician before combining with other nasal decongestants or sympathomimetic agents. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with certain medications, affecting its safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive crisis. - Other nasal decongestants: combined vasoconstriction can cause excessive blood pressure rise.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may reduce effectiveness of blood pressure control. - Tricyclic antidepressants: potential additive sympathomimetic effects. - Beta‑blockers: may blunt cardiovascular response, requiring monitoring.